ERBB2 and breast cancer: In the present investigation, the deep and straightforward lipid analysis allowed by the 1H-NMR platform has revealed that HER2-positive BC may induce lipid alterations of specific Chol-VLDL subfractions such as the low size VLDL-1,2,3 which are commonly disregarded by routine clinical lipid tests.